Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 541925 of 542236 entries
View as:

MyoRing Implantation With Corneal Collagen Crosslinking for Keratoconus

Phase: N/A Priority: Normal
NCT ID: NCT02590549 Org: User:
Start: 01/31/11 End: 12/31/14 Due: 12/31/15

Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel

Phase: N/A Priority: Normal
NCT ID: NCT04431349 Org: User:
Start: 01/01/16 End: 05/06/20 Due: 05/06/21

An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03349073 Org: User:
Start: 09/14/17 End: 06/24/19 Due: 06/24/20

A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04452214 Org: User:
Start: 09/24/20 End: 06/28/23 Due: 06/28/24

Sleep Assessment: The Benefits of Identifying Sleep Disturbance Using a Sleep Questionnaire

Phase: N/A Priority: Normal
NCT ID: NCT06074224 Org: User:
Start: 01/01/22 End: 11/01/23 Due: 11/01/24

Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers

Phase: N/A Priority: Normal
NCT ID: NCT01344824 Org: User:
Start: 03/31/10 End: 07/20/16 Due: 07/20/17

Garlic Product Impact on Periodontitis (GPIP)

Phase: N/A Priority: Normal
NCT ID: NCT03492723 Org: User:
Start: 04/17/18 End: 04/30/20 Due: 04/30/21

The State of Play in Picardy of the Knowledge of the Elderly at Risk of Falling at Home in Terms of Prevention and Evaluation.

Phase: N/A Priority: Normal
NCT ID: NCT03132857 Org: User:
Start: 03/12/17 End: 12/16/17 Due: 12/16/18

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04947774 Org: User:
Start: 11/01/20 End: 10/31/22 Due: 10/31/23

Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02499367 Org: User:
Start: 08/31/15 End: 08/31/25 Due: 08/31/26

Vitamin C Chewing Gum, Pregnancy Nausea and Vomiting

Phase: N/A Priority: Normal
NCT ID: NCT06246240 Org: User:
Start: 10/08/23 End: 03/05/24 Due: 03/05/25

Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03097341 Org: User:
Start: 06/05/17 End: 01/16/18 Due: 01/16/19

Close Obstructive Sleep Apnea (OSA) Trial

Phase: N/A Priority: Normal
NCT ID: NCT06113562 Org: User:
Start: 02/01/25 End: 02/11/25 Due: 02/11/26

Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19

Phase: N/A Priority: Normal
NCT ID: NCT03942458 Org: User:
Start: 04/03/19 End: 09/03/19 Due: 09/03/20

A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06554574 Org: User:
Start: 09/03/24 End: 09/30/25 Due: 09/30/26

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

Phase: N/A Priority: Normal
NCT ID: NCT06122649 Org: User:
Start: 11/27/23 End: 12/07/25 Due: 12/07/26

Search for Bovine miRNA Transference to Humans

Phase: N/A Priority: Normal
NCT ID: NCT03740087 Org: User:
Start: 04/13/15 End: 05/22/16 Due: 05/22/17

Deep Squat, Cross-Legged Sitting and Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT06852677 Org: User:
Start: 03/31/25 End: 08/31/25 Due: 08/31/26

Benzo[a]Pyrene Ultralow Dose-Response Study

Phase: N/A Priority: Normal
NCT ID: NCT03318978 Org: User:
Start: 04/17/18 End: 02/01/24 Due: 02/01/25

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06096623 Org: User:
Start: 11/06/23 End: 05/31/26 Due: 05/31/27

FITBIT Study on Mobility and Readmissions After Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT04314778 Org: User:
Start: 11/15/19 End: 08/15/22 Due: 08/15/23

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Phase: N/A Priority: Normal
NCT ID: NCT04552288 Org: User:
Start: 09/16/20 End: 03/16/26 Due: 03/16/27

OFA in Thoracic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05063396 Org: User:
Start: 10/01/21 End: 12/01/25 Due: 12/01/26

Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Phase: N/A Priority: Normal
NCT ID: NCT06067802 Org: User:
Start: 07/31/25 End: 07/31/27 Due: 07/31/28

Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02844816 Org: User:
Start: 03/13/17 End: 06/26/24 Due: 06/26/25